Y. Gamallat Et Al. , "Exploring The Prognostic Significance of SET-Domain Containing 2 (SETD2) Expression in Advanced and Castrate-Resistant Prostate Cancer," Cancers , vol.16, no.7, 2024
Gamallat, Y. Et Al. 2024. Exploring The Prognostic Significance of SET-Domain Containing 2 (SETD2) Expression in Advanced and Castrate-Resistant Prostate Cancer. Cancers , vol.16, no.7 .
Gamallat, Y., Felipe Lima, J., Seyedi, S., Li, Q., Rokne, J. G., Alhajj, R., ... Ghosh, S.(2024). Exploring The Prognostic Significance of SET-Domain Containing 2 (SETD2) Expression in Advanced and Castrate-Resistant Prostate Cancer. Cancers , vol.16, no.7.
Gamallat, Yaser Et Al. "Exploring The Prognostic Significance of SET-Domain Containing 2 (SETD2) Expression in Advanced and Castrate-Resistant Prostate Cancer," Cancers , vol.16, no.7, 2024
Gamallat, Yaser Et Al. "Exploring The Prognostic Significance of SET-Domain Containing 2 (SETD2) Expression in Advanced and Castrate-Resistant Prostate Cancer." Cancers , vol.16, no.7, 2024
Gamallat, Y. Et Al. (2024) . "Exploring The Prognostic Significance of SET-Domain Containing 2 (SETD2) Expression in Advanced and Castrate-Resistant Prostate Cancer." Cancers , vol.16, no.7.
@article{article, author={Yaser Gamallat Et Al. }, title={Exploring The Prognostic Significance of SET-Domain Containing 2 (SETD2) Expression in Advanced and Castrate-Resistant Prostate Cancer}, journal={Cancers}, year=2024}